Corinne Hoff
No más puestos en curso
Perfil
Ms. Corinne Hoff is a Director-Communications & Investor Relations at Exonhit.
Ms. Hoff was previously employed as Leiter Finanzielle Medienverhältnisse by Novartis AG.
Antiguos cargos conocidos de Corinne Hoff.
Empresas | Cargo | Fin |
---|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Public Communications Contact | 20/12/2012 |
NOVARTIS AG | Public Communications Contact | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVARTIS AG | Health Technology |
Empresas privadas | 1 |
---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
- Bolsa de valores
- Insiders
- Corinne Hoff